This Week in Startups avatar

Dexa/This Week in Startups

Learn more
Published Oct 20, 2022

Next Unicorns evaluation + Ask Jason | E1590

Jason Calacanis delves into the evolution of potential unicorns like Checker and Benchling, examines skyrocketing startup valuations and late-stage venture capital nuances, and explores groundbreaking AI innovations revolutionizing creativity and industry workflows.
Episode Highlights
This Week in Startups logo

Topics covered

Popular Clips

Episode Highlights

  • Innovative Tools

    Innovative AI tools are reshaping industries by simplifying complex tasks and enhancing creativity. highlights the potential of AI in logo design, where software can now generate brand names and check domain availability, reducing costs significantly 1. He envisions AI tools that could assist in screenplay writing or joke creation, offering creative professionals new ways to generate content.

    I would love to see somebody create a dolly version of a screenplay writing software where it just gave you ideas on what should happen in your screenplay or character ideas.

    ---

    These innovations promise to make creative processes more accessible and efficient, opening up new possibilities for entrepreneurs and artists alike.

       

    AI Revolution

    The AI revolution is gaining momentum, with 2023 poised to be a pivotal year for its widespread adoption. Jason notes that the accessibility of AI and machine learning tools has increased, with thousands now able to utilize these technologies 2. This democratization allows developers to tackle complex problems more efficiently, such as optimizing sales strategies or predicting emerging trends on platforms like TikTok.

    The next year or two in startup land is going to be developers and founders playing with AI tools, computer vision, machine learning.

    ---

    As AI becomes more integrated into various sectors, its potential to transform industries and enhance productivity is immense.

       

    Biotech AI

    AI and machine learning are revolutionizing biotech, particularly in drug discovery and development. Jason discusses 's startup, Insitro, which uses machine learning to accelerate drug development and improve accuracy 3. This approach leverages big data and advanced computing to identify promising drug candidates more efficiently than traditional methods.

    We are in a position where there has been a set of tools that have been developed by bioengineers and cell biologists that all of a sudden give us the opportunity to measure biology at unprecedented fidelity and scale.

    ---

    Such innovations highlight the transformative potential of AI in healthcare, offering new hope for tackling complex diseases.

Related Episodes